Cohen Fred E — SEC insider filings
SEC reporting owner CIK 1339358. 35 insider filings on record with FilingPulse; latest filed 2026-11-04.
Transaction summary — filings shown
Covers all 35 filings on record, filed 2020-09-22 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 150,000 shares, $1,402,500 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 62.
- Largest priced transaction: purchase of 150,000 shares @ $9.35 ($1,402,500) in Intellia Therapeutics, Inc., filed 2026-01-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | Director | 8 | 1 leg · 150,000 sh · $1,402,500 | — | 14 |
| CareDx, Inc. (CDNA) | Director | 12 | — | — | 20 |
| Progyny, Inc. (PGNY) | Director | 6 | — | — | 13 |
| Kyverna Therapeutics, Inc. (KYTX) | Director | 3 | — | — | 8 |
| UroGen Pharma Ltd. (URGN) | Director | 5 | — | — | 5 |
| VERACYTE, INC. (VCYT) | Director | 1 | — | — | 2 |
Insider filings — Cohen Fred E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | CareDx, Inc. (CDNA) | Gift (G): 25,000 @ $0 | EDGAR |
| 2026-06-16 | 4 | CareDx, Inc. (CDNA) | Grant/award (A): 9,795 @ $0 | EDGAR |
| 2026-06-10 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 9,200 @ $0 · Grant/award (A): 13,300 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Kyverna Therapeutics, Inc. (KYTX) | Grant/award (A): 5,093 @ $0 · Grant/award (A): 20,582 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Intellia Therapeutics, Inc. (NTLA) | Purchase (P): 150,000 @ $9.35 | EDGAR |
| 2025-06-17 | 4 | CareDx, Inc. (CDNA) | Grant/award (A): 12,103 @ $0 | EDGAR |
| 2025-06-13 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 11,450 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Kyverna Therapeutics, Inc. (KYTX) | Grant/award (A): 16,634 @ $0 · Grant/award (A): 65,351 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4/A | CareDx, Inc. (CDNA) | Grant/award (A): 16,048 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | CareDx, Inc. (CDNA) | Grant/award (A): 10,570 @ $0 · Grant/award (A): 16,048 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 7,737 @ $0 · Grant/award (A): 11,515 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Progyny, Inc. (PGNY) | Grant/award (A): 6,176 @ $0 · Grant/award (A): 25,070 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Kyverna Therapeutics, Inc. (KYTX) | Conversion (C): 4,523,924 · Conversion (C): 4,401,771 (derivative) @ $0 · Conversion (C): 8,830,901 (derivative) @ $0 · Conversion (C): 7,356,162 (derivative) @ $0 | EDGAR |
| 2023-09-08 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-07-28 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 69,339 @ $9.54 | EDGAR |
| 2023-06-21 | 4 | CareDx, Inc. (CDNA) | Grant/award (A): 18,844 @ $0 · Grant/award (A): 29,136 (derivative) @ $0 | EDGAR |
| 2023-06-16 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 4,425 @ $0 · Grant/award (A): 6,473 (derivative) @ $0 | EDGAR |
| 2023-05-26 | 4 | Progyny, Inc. (PGNY) | Grant/award (A): 4,385 @ $0 · Grant/award (A): 18,350 (derivative) @ $0 | EDGAR |
| 2023-01-09 | 4 | CareDx, Inc. (CDNA) | Grant/award (A): 1,062 @ $0 | EDGAR |
| 2022-10-26 | 4 | Progyny, Inc. (PGNY) | Grant/award (A): 3,480 @ $0 · Grant/award (A): 15,660 (derivative) @ $0 · Grant/award (A): 1,460 (derivative) @ $0 | EDGAR |
| 2022-10-04 | 4 | CareDx, Inc. (CDNA) | Grant/award (A): 803 @ $0 | EDGAR |
| 2022-06-21 | 4 | CareDx, Inc. (CDNA) | Grant/award (A): 4,863 @ $0 · Grant/award (A): 7,606 (derivative) @ $0 | EDGAR |
| 2022-06-16 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 5,197 @ $0 · Grant/award (A): 7,688 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2021-10-26 | 4 | Progyny, Inc. (PGNY) | Grant/award (A): 2,652 @ $0 · Grant/award (A): 15,831 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 2,094 @ $0 · Grant/award (A): 3,382 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | CareDx, Inc. (CDNA) | Grant/award (A): 1,127 @ $0 · Grant/award (A): 1,812 (derivative) @ $0 | EDGAR |
| 2021-06-09 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 20,000 @ $13.78 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2021-01-06 | 4 | CareDx, Inc. (CDNA) | Option exercise (M): 15,000 @ $14.74 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2020-11-20 | 4/A | Progyny, Inc. (PGNY) | Grant/award (A): 1,845 (derivative) @ $0 | EDGAR |
| 2020-10-27 | 4 | Progyny, Inc. (PGNY) | Grant/award (A): 6,000 @ $0 · Grant/award (A): 27,000 (derivative) @ $0 · Grant/award (A): 894 (derivative) @ $27.95 | EDGAR |
| 2020-10-20 | 4 | VERACYTE, INC. (VCYT) | Option exercise (M): 10,000 @ $7.60 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2020-09-22 | 4 | CareDx, Inc. (CDNA) | Option exercise (M): 6,679 @ $5.49 · Option exercise (M): 9,745 @ $4.95 · Option exercise (M): 6,679 (derivative) @ $0 · Option exercise (M): 9,745 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1339358 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs